Fig. 6
From: Sex and estrogens alter the action of glucagon-like peptide-1 on reward
MPPd treatment did not attenuate the effects of central Ex4 treatment on food intake. Central injection with the GLP-1R agonist Ex4 significantly reduced peanut butter intake and chow intake in males (a, b) and females (c, d). The reduction was still present after treatment with the ERα-antagonist MPPd. Chow and peanut butter consumption are displayed in grams. Data are expressed as mean ± SEM. n = 7–9 for males and females. **p < 0.01, ***p < 0.001